- University News Archive - 糖心Vlog传媒 Little Rock /news-archive/tag/nucress-scaffold/ 糖心Vlog传媒 Little Rock Wed, 20 Nov 2019 15:35:48 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 糖心Vlog传媒 Little Rock announces $750,000 grant for bone regeneration technology during Sen. Boozman鈥檚 visit to review research innovations /news-archive/2019/11/20/ua-little-rock-announces-750000-grant-for-bone-regeneration-technology-during-sen-boozmans-visit-to-review-research-innovations/ Wed, 20 Nov 2019 15:35:48 +0000 /news/?p=75774 ... 糖心Vlog传媒 Little Rock announces $750,000 grant for bone regeneration technology during Sen. Boozman鈥檚 visit to review research innovations]]> The University of Arkansas at Little Rock announced a $750,000 grant from the U.S. Department of Defense to support the development of potentially life-saving bone regeneration technology during a Nov. 15 visit from Sen. John Boozman. The visit celebrated on-campus research initiatives that the senator championed for federal support.听 Pioneered at the 糖心Vlog传媒 Little Rock Center for Integrative Nanotechnology Sciences, the NuCress鈩 scaffold is a multifunctional device designed to promote controlled, robust bone regeneration in fractures, gaps where bone is missing, and major injury defects, including previously untreatable catastrophic injuries. Such a technology is highly needed by a wide variety of patients, including wounded soldiers, victims of major accidents and trauma, and those with various bone diseases. The $750,000 grant, provided by the Department of Defense鈥檚 Peer Reviewed Orthopaedic Research Program, will investigate the scaffold鈥檚 ability to combat infection while regenerating bone. Earlier this fall, 糖心Vlog传媒 Little Rock received a $5.6 million grant from the Department of Defense to fund the pre-market development of the same bone regeneration technology. Sen. Boozman supported both grants during the application stages.听 鈥淭he commitment by DOD to continue advancing bone regeneration technology demonstrates the importance of this research and the opportunities it presents for our wounded warriors,鈥 Sen. Boozman said. 鈥淚鈥檓 proud to support this award so we can discover breakthroughs, spark innovation, and achieve things we might have thought were impossible. This and other important research being conducted at 糖心Vlog传媒 Little Rock is essential to moving us forward and gives Arkansas something to be very proud of.鈥 During the visit to 糖心Vlog传媒 Little Rock鈥檚 nanotechnology center, Sen. Boozman met with faculty and student researchers and toured the labs in which the NuCress鈩 scaffold听 materials are developed. The bone regeneration research is led by researchers at 糖心Vlog传媒 Little Rock (principal investigator Dr. Alexandru Biris), the University of Arkansas for Medical Sciences (principal investigator Dr. Mark Smeltzer), and the University of Tennessee, Knoxville (principal investigator Dr. David Anderson).
Sen. John Boozman and member of his staff visit with the researchers at 糖心Vlog传媒 Little Rock's Center for Integrative Nanotechnology Sciences.

Sen. John Boozman and members of his staff visit with the researchers at 糖心Vlog传媒 Little Rock’s Center for Integrative Nanotechnology Sciences.

鈥淲e are honored by both the DOD鈥檚 and Sen. Boozman鈥檚 continued support of our research,鈥 Biris said. 鈥淲ithout it, we could not continue to develop this potentially life-changing technology.鈥 The NuCress鈩 bone regeneration scaffold also recently received a TechConnect Defense Innovation award for the second consecutive year. Judged by a team of military and industry experts, the award is given to the top 15 percent of submissions to the annual Defense TechConnect Summit and Expo. Award selections are based on the potential positive impact the technology will have for the military and national security. The award was presented to NuShores Biosciences LLC, the licensee of the NuCress鈩 scaffold. 鈥淭he recognition of our NuCress鈩 technologies by the Expo judges is gratifying and much appreciated,鈥 NuShores CEO Sharon Ballard said. 鈥淭his year鈥檚 conference validated the marketplace need for our initial orthopedic product and for applying our NuCress鈩 technologies to new medical indications.鈥 Additionally, Sen. Boozman met with Dr. Nitin Agarwal, Jerry L. Maulden-Entergy endowed chair and distinguished professor of information science, who received a $2.4 million grant from the Department of Defense earlier this year to develop ways to track emerging cyber-social threats and strengthen social cybersecurity research infrastructure. Sen. Boozman also supported this effort. Agarwal updated Sen. Boozman on how technology being developed at 糖心Vlog传媒 Little Rock in the Collaboratorium for Social Media and Online Behavioral Studies (COSMOS) has been used to track malicious activities, including the dissemination of propaganda, hoaxes, and disinformation to influence beliefs and behaviors. These technologies include Blogtrackers and YouTubeTracker.
Sen. John Boozman, his staff, and 糖心Vlog传媒 Little Rock members hear a research update from Dr. Nitin Agarwal.

Sen. John Boozman, his staff, and 糖心Vlog传媒 Little Rock members hear a research update from Dr. Nitin Agarwal.

In this most recent grant, Agarwal will develop research infrastructure to assess social media, specifically blogs and YouTube, in real time and respond to the growing weaponization of online discourse in influencing peacekeeping, and tactical, operational, and strategic operations. The research infrastructure will include development of models, software applications, and training programs. Military units at all levels will benefit from the intended goals of the project in identification of threats and opportunities within the information environment. 鈥淲e are thankful to Senator John Boozman for supporting the social networking research at 糖心Vlog传媒 Little Rock,鈥 Agarwal said. 鈥淭he senator recognizes the importance of developing new approaches, software tools, and training programs for national security in cyberspace, and this grant was enabled through his support of funding for the Navy鈥檚 Social Networks Analysis program.鈥 The U.S. Army Medical Research Acquisition Activity, 839 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work is supported by the Department of Defense, through the Joint Warfighter Medical Research Program under Award No. W81XWH1920014 and through the Peer Reviewed Orthopaedic Research Program under Award No. W81XWH1910742.听 Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. ]]>
NuShores Biosciences receives $1.7 million grant to study bone regeneration technology /news-archive/2018/09/20/nushores-biosciences-receives-1-7-million-grant-to-study-bone-regeneration-technology/ Thu, 20 Sep 2018 13:10:30 +0000 /news/?p=71913 ... NuShores Biosciences receives $1.7 million grant to study bone regeneration technology]]> A University of Arkansas at Little Rock spin-off company, has received a $1.7 million grant to study how NuShores鈥 bone regeneration technology can be applied in craniofacial tissues.听 The National Institute of Dental and Craniofacial Research, a component of the National Institutes of Health, has awarded the company a 2.5-year Small Business Innovation Research (SBIR) Fast Track grant to study the NuCress鈩 bone filler scaffold鈥檚 ability to facilitate dental implants in the jaw. 鈥淭his NIH award is a direct result of the profound study results in long bone delivered by our research collaborators at 糖心Vlog传媒 Little Rock and the University of Tennessee College of Veterinary Medicine. The reviewers were able to clearly see the potential in dental applications for this technology. I鈥檓 excited to work with world-class clinicians to study the NuCress鈩 scaffold for the future benefit of their patients,鈥 states Sharon Ballard, NuShores鈥 CEO. The NuCress鈩 scaffold is a nanomaterial-based bone regeneration device developed for large segmental defects. This development is led by Dr. Alex Biris, the director and chief scientist of the 糖心Vlog传媒 Little Rock Center for Integrative Nanotechnology Sciences and a professor of systems engineering in the Donaghey College of Engineering and Information Technology. 鈥淭his is a significant win to expand NuShores鈥 technology, made possible through our university relationships, Arkansas鈥 small business development infrastructure, and tireless work by a dedicated team. We are grateful,鈥 said Biris.
NuShores Biosciences, LLC

NuShores Biosciences, LLC

NuShores has partnered with Stony Brook University School of Dental Medicine on this grant. If successful, the scaffold will be a transformational tool for surgeons involved in bone regeneration in a variety of fields. Founded in 2014, NuShores has the exclusive, global license from 糖心Vlog传媒 Little Rock to commercialize university-owned patented and patent-pending technologies related to the NuCress鈩 scaffold. The company has received assistance from the Arkansas Small Business and Technology Development Center. The NuCress鈩 scaffold has already given a number of animals a new lease on life. For example, just last year, it was used at the University of Tennessee College of Veterinary Medicine to heal Hercules, an alpaca who broke his leg on his ranch in Lebanon, Tennessee, at only 24 hours old. The open wound and exposed bone led to a serious infection, which prevented the bone from healing properly. Against the odds, the scaffold eliminated the infection and completely regenerated the missing bone. Thanks to the NuCress鈩 scaffold, Hercules is now a thriving member of his herd. About the SBIR Program The SBIR program involves 11 federal agencies investing more than $3 billion a year in high risk/high payoff research and development conducted by the nation鈥檚 leading science-technology innovators. NuShores鈥 award is known as a Fast Track Grant, where funding occurs when SBIR Phase I and Phase II proposals are peer reviewed at the same time and granted in a single award. This approach expedites funding and research for the companies. Research described in this press release is supported by the National Center for Dental and Craniofacial Research of the National Institutes of Health under award number 1R44DE028213-01.]]>
糖心Vlog传媒 Little Rock reseachers pioneer device to speed bone regeneration /news-archive/2017/12/05/nucress/ Tue, 05 Dec 2017 18:13:31 +0000 /news/?p=68728 ... 糖心Vlog传媒 Little Rock reseachers pioneer device to speed bone regeneration]]> Center for Integrative Nanotechnology Sciences (CINS) at 糖心Vlog传媒 Little Rock and researchers at the . This technology, the NuCress鈩 scaffold, is a nanomaterial-based bone regeneration device pioneered by 糖心Vlog传媒 Little Rock鈥檚 Dr. Alexandru S. Biris, a systems engineering professor, Roy and Christine Sturgis Charitable Trust Nanotechnology chair, and director of the Center for Integrative Nanotechnology Sciences. Biris鈥檚 long-time research partner, Dr. David Anderson, is professor and head of Large Animal Clinical Sciences at the (UTCVM). Together, Biris, Anderson, and their teams have designed, patented, and tested the NuCress鈩 scaffold. The scaffold is implanted directly at the wound site by a surgeon and can be loaded with drugs to fight infection or with hormones and stem cells to encourage bone growth. As a result, the scaffold can deliver bacteria-fighting drugs directly to the wound site and be safely absorbed by the body鈥攇enerally eliminating the need for additional surgeries. It is currently in the preclinical stages of development. Supported by funding from the U.S. Department of Defense, the NuCress鈩 scaffold is showing great promise in preliminary studies. But this year, it has听moved out of the lab and into the field, restoring two severely injured animals to full health. Healing Hercules
Hercules the alpaca

Hercules the alpaca

Hercules the alpaca was only 24 hours old when he broke his leg on his ranch in Lebanon, Tennessee. The baby animal received a plasma transfusion and was bottle-fed for months. To make matters worse, the open wound and exposed bone led to a serious infection, which prevented the bone break from healing properly. As a result, the animal鈥檚 veterinarian referred him to UTCVM for advanced treatment. Dr. Pierre-Yves Mulon, UTCVM assistant professor in Farm Animal Medicine and Surgery, was the expert orthopedic surgeon who oversaw Hercules鈥檚 case. Having worked with both the latest commercially available technologies and the NuCress鈩 scaffold, Mulon determined that the scaffold was the best option to heal the fragile animal. He trimmed the scaffold to match the break, loaded it with antibiotics, implanted it in the wound鈥nd waited. Given Hercules鈥檚 condition, Mulon expected a long road to recovery. But the NuCress鈩 scaffold quickly exceeded expectations. 鈥淗ercules responded well and fast,鈥 Mulon said. 鈥淗e was able to walk immediately after surgery and has been very active. The bone repaired within the time range expected for a closed fracture, though it was an open one.鈥 Mulon explained that while other options, such as traditionally administered drugs or implantable antimicrobial beads, could have been used, they would have presented more obstacles, such as future surgeries. 鈥淚t is difficult to confirm if the results would have changed using any other option; however, I think it would have necessitated more time,鈥 said Mulon, adding, 鈥淎ny open fracture carries a guarded to poor prognosis, and Hercules made it, and we are very happy.鈥 Joining the Rodeo A much tougher test of the scaffold鈥檚 abilities came this fall, with much higher stakes. Mulon was faced with a gravely injured prize breeding cow in the rodeo industry. Considered a genetic founder of the herd, this pricey bovine was suffering from a complicated, chronic bone infection in her leg. The infection was so severe that the cow had already undergone one unsuccessful surgery, and options were limited. Traditional treatments, with their need for future surgeries and their delayed infection fighting, could have actually harmed the vulnerable cow more.
Dr. Pierre-Yves Mulon, assistant professor in Farm Animal Medicine and Surgery, University of Tennessee College of Veterinary Medicine

Dr. Pierre-Yves Mulon, assistant professor in Farm Animal Medicine and Surgery, University of Tennessee College of Veterinary Medicine

Time was running out. Remembering Hercules鈥 remarkable results, Mulon and the animal鈥檚 owner decided to take a risk. Mulon implanted an antibiotic-loaded NuCress鈩 scaffold in the cow鈥檚 injured leg. Though he was hopeful that the scaffold would work a miracle, Mulon gave the animal鈥檚 owner a bleak prognosis鈥攛-rays indicated that the wound could be too far gone to heal. 鈥淪he was suffering such a deep orthopedic infection that鈥he would have been put to sleep if the bone infection could not be resolved,鈥 Mulon said. But, once again, the NuCress鈩 scaffold exceeded expectations. The infection completely healed, and, after a lengthy recovery, the cow is back home and well on her way to being a functioning member of the herd again. 鈥淚 strongly believe that the slow release of antibiotics over a prolonged period of time [by the scaffold] helped this cow tremendously and led to the successful outcome,鈥 Mulon asserted. 鈥淚 have not seen any product comparable to this one.鈥 Looking to the Future Having worked on the scaffold for over a decade, Biris and Anderson share Mulon鈥檚 enthusiasm. 鈥淲e are very happy that these animals are benefiting from the technology,鈥 Biris said. But alpacas and cows are just the beginning of the scaffold鈥檚 story. Supported by an over $5 million grant from the Department of Defense, Biris, Anderson, and their teams are optimizing the NuCress鈩 scaffold for use in long bone. Additionally, 鈥攖he company commercializing the device鈥攊s preparing to apply to the U.S. Food and Drug Administration for regulatory approval of the scaffold, moving it one step closer to human use. The teams also are seeking funding to expand the scaffold鈥檚 uses to other types of wounds and areas of the body. If successful, the NuCress鈩 scaffold could become an essential part of the bone-healing process for injured soldiers, car accident victims, cancer survivors, and more. Contributing Writer: 听Emily Davis, Content/Grant Writer, Center for Integrative Nanotechnology Sciences This work was supported by the U.S. Army Medical Research and Materiel Command Congressionally Directed Medical Research Programs, Defense Medical Research and Development Program, under Award No. W81XWH-15-1-0666. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. In conducting research using animals, the investigator(s) adheres to the laws of the United States and regulations of the Department of Agriculture.]]>